Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Compatibility
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Safety.
- Status
- COMPLETED
- Phase
- PHASE3
Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy With or Without Enoxaparin in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) - Safety
- Status
- COMPLETED
- Phase
- PHASE3
First-line Therapy of Stage IV Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid)- Compatibility
- Status
- COMPLETED
- Phase
- PHASE3
Dermacyd Breeze (Lactic Acid) Pocket BR - Compatibility
- Status
- COMPLETED
- Phase
- PHASE3
Dermacyd Breeze (Lactic Acid) Pocket BR - Photo Evaluation
- Status
- COMPLETED
- Phase
- PHASE3
Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Photo Evaluation
- Status
- COMPLETED
- Phase
- PHASE3
Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.
- Status
- COMPLETED
- Phase
- PHASE3
Dermacyd Femina (Lactic Acid) Pocket BR - Compatibility
- Status
- COMPLETED
- Phase
- PHASE3
Insulin Glargine Combination Therapies in Type II Diabetics
- Status
- COMPLETED
- Phase
- PHASE3
Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Photo Evaluation
- Status
- COMPLETED
- Phase
- PHASE3
Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation
- Status
- COMPLETED
- Phase
- PHASE3
Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate
- Status
- COMPLETED
- Phase
- N/A
Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol
- Status
- COMPLETED
- Phase
- PHASE2
Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2